However, further investigation needs be performed to reveal the relation between N-cadherin or other EMT markers/inducers and key parameters for new 2016 WHO glioma classification, such as IDH1 mutation, 1p/19q co-deletion or MGMT promoter methylation [31]. The gene discussed is CDH2; the disease is glioma.